What Should Clinicians Do for Older Adults with Polypharmacy and Depression? [Response to Letter]

Cheng Cheng1 School of Nursing, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]

Jie Bai2 Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China

References

Cheng C, Bai J. Association Between Polypharmacy, Anxiety, and Depression Among Chinese Older Adults: evidence from the Chinese Longitudinal Healthy Longevity Survey. Clin Interv Aging. 2022;17:235–244. doi:10.2147/cia.S351731
PubMed Web of Science ®Google Scholar
Li C, Zhou R, Yao N, Cornwell T, Wang S. Health Care Utilization and Unmet Needs in Chinese Older Adults With Multimorbidity and Functional Impairment. J Am Med Dir Assoc. 2020;21(6):806–810. doi:10.1016/j.jamda.2020.02.010
PubMed Web of Science ®Google Scholar
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi:10.1517/14740338.2013.827660
PubMed Web of Science ®Google Scholar
Palapinyo S, Methaneethorn J, Leelakanok N. Association between polypharmacy and depression: a systematic review and meta-analysis. J Pharm Practice Res. 2021;51(4):280–299. doi:10.1002/jppr.1749
Web of Science ®Google Scholar
Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165–CD008165. doi:10.1002/14651858.CD008165.pub4
PubMed Web of Science ®Google Scholar